titan pharmaceuticals inc (TTNP:OTC BB)

Executive Profile*

Background*

Dr. Marc Rubin, MD is a Biopharmaceutical Consultant. Dr. Rubin is the Founder of Titan Pharmaceuticals Inc. and served as its Chief Executive Officer and President from October 1, 2007 to December 2008. He joined Titan in October 2007. He served as a Member of Executive Board of Bayer Pharma AG (formerly, Schering Aktiengesellschaft) from October 1, 2003 to February 2007, its Member of Board of Management from September 14, 2006 to January 2007 and also served as its ... Head of Global Research and Development from June 2006 to February 2007. Prior to his position at Bayer Schering Pharma, Dr. Rubin served as Member of the Executive Board and President of Development for Schering AG from October 2003 to June 2006. He served as President of Berlex Pharmaceuticals, a division of Schering AG. Before joining Schering AG, from 1990 to August 2003, Dr. Rubin employed by GlaxoSmithKline where he held positions of responsibility in global clinical and commercial development overseeing programs in the United States, Europe, Asia and Latin America and served as its Director of Infectious Diseases Clinical Research in the USA since 1990 and he served as Senior Vice President of Global Clinical Pharmacology & Discovery Medicine from 2001 to 2003. Dr. Rubin has been an Executive Chairman of Titan Pharmaceuticals Inc. since May 2009 and served as its Chairman. He served as Senior Staff at the National Institutes of Health from 1986 to 1989. He served as the Chairman and Director of Schering Berlin Inc. He has been a Director of Galectin Therapeutics, Inc. since October 12, 2011. Dr. Rubin has been a Director of Titan Pharmaceuticals Inc. since November 01, 2007; Gemmus Pharma Inc. since August 01, 2012 and Curis Inc. since June 2010. He serves as a Director of Surface Logix, Inc. He served as Executive Director of Bayer Schering Pharma AG since July 7, 2003. Dr. Rubin served as a Director of Medarex, Inc. from November 2007 to September 2009. He serves as Director of Rogosin Institute, a not-for-profit medical treatment and research institution. Dr. Rubin completed his clinical training in internal medicine at The Johns Hopkins Hospital and, in 1986, subspecialty training in both oncology and infectious disease at the National Institutes of Health, where he remained in a Senior Staff position till 1989. Dr. Rubin did his undergraduate work at Cornell University and Cornell University Medical College, New York, and holds an M.D. Degree from the Cornell University Medical College in 1980.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
TTNP:US	$0.54 USD	-0.0069

COMPETITOR COMPENSATION